Logo
ojaswini cmi3 @go_66a1ea66c061d
Immuno-Oncology Assays Market to Witness High Growth Owing to Rising Cancer Prevalence

The Immuno-Oncology Assays Market encompasses a suite of advanced diagnostic tests designed to measure immune responses against tumor antigens, enabling precision in cancer immunotherapy selection and monitoring. These assays—ranging from ELISA-based cytokine profiling to high-throughput flow cytometry panels—offer advantages such as high specificity, reproducibility, and adaptability to multiplex formats.
As immuno-oncology and checkpoint inhibitor therapies gain traction, the need for robust companion diagnostics and biomarker validation platforms has surged. Pharmaceutical companies, contract research organizations, and academic institutes rely on these assays for drug development, patient stratification, and real-time monitoring of therapeutic efficacy

Immuno-Oncology Assays Market

https://www.coherentmarket...

Get More Insights On Immuno-Oncology Assays Market
https://justpaste.it/k2v6i

#Immuno -OncologyAssaysMarket, #Immuno -OncologyAssaysMarketsize, #Immuno -OncologyAssaysMarketshare,#Immuno-OncologyAssaysMarketApplication,#Immuno-OncologyAssaysMarket
06:31 AM - May 20, 2025 (UTC)

No replys yet!

It seems that this publication does not yet have any comments. In order to respond to this publication from ojaswini cmi3, click on at the bottom under it